Amcor (AMCR) Q4 2026 earnings review
Volumes Turn Positive as Synergies Supercharge Earnings
Amcor finished FY26 on a strong note, reporting a 26% revenue surge to $6.40B and a 23% jump in Adjusted EPS to $1.23. The headline growth was largely structural—driven by the anniversary of the Berry acquisition—but the underlying story is a crucial inflection point: organic volumes finally reversed their multi-quarter decline, growing ~0.5%. Coupled with synergy realization running ahead of schedule, this volume leverage allowed Adjusted EBIT margins to expand aggressively in both major segments. The company is now transitioning its fiscal year-end to December and guided for $1.80-$1.90 Adjusted EPS for the upcoming six-month stub period.
🐂 Bull Case
After a grueling period of industry-wide destocking and soft demand, total comparable volumes inflected positive (+0.5%). Growth was broad-based, led by Pet Food, Protein, and Emerging Markets (Asia).
The Berry integration is yielding massive cost and productivity benefits. Adjusted EBIT surged 37%, far outpacing revenue growth, pushing Flexibles margins above 15% and Rigids above 12%.
🐻 Bear Case
Net debt sits at nearly $12.9B. With December 2026 leverage guided to 3.5x-3.6x, the path to the <3.0x target—and the return of share buybacks—remains extended.
Despite a massive raw material pass-through, the organic price/mix was actually negative (-1%), indicating potential consumer trade-down or pricing concessions.
⚖️ Verdict: 🟢
Bullish. The hardest part of the packaging cycle—volume contraction—appears to be reversing. With the synergy engine running smoothly, any sustained volume growth will drive outsized earnings expansion.
Key Themes
Inflection Point: Volumes Reversing to Growth
The most important data point in this print is the ~0.5% volume growth compared to combined legacy Amcor/Berry businesses. This marks a clear reversing trend from the -2.5% trough in Q2 and -1.5% in Q3. Global Flexible Packaging volumes rose ~1% (driven by pet food and protein), while Global Rigid Packaging volumes rose ~0.5% (driven by foodservice and beauty). This volume leverage is the critical missing piece for organic growth.
Berry Synergies Accelerating Earnings
The integration of Berry Global continues to be the dominant driver of margin expansion. In Q4 alone, synergies contributed ~$100 million to EBIT. For the full year, synergies delivered ~$240 million. This structural cost removal allowed Adjusted EBIT to grow 37% in Q4 on just 26% reported revenue growth, insulating the bottom line from macro volatility.
Complex Packaging Innovation Winning Share
Amcor's scale in highly technical, complex packaging segments continues to be a commercial driver. The combined Amcor/Berry portfolio allows the company to act as a one-stop-shop (e.g., providing both blister packaging and rigid containers for high-growth GLP-1 pharmaceutical drugs), securing 'systems' sales rather than component sales.
Negative Price/Mix Contradicts Pricing Power Narrative
Management frequently touts its ability to manage inflation and maintain pricing power. However, the data contradicts this perfection: despite passing through $280 million in higher raw material costs, the actual price/mix impact on comparable organic sales was an unfavorable (1%) in Q4. This suggests that while Amcor can mechanically pass on resin costs, customers may be pushing back on base pricing or mixing down to lower-margin products.
Unprecedented Input Cost Inflation (Macro)
The macroeconomic environment remains turbulent, highlighted by an estimated $280M favorable revenue impact in Q4 solely from passing through higher raw material costs (a 6% artificial lift to sales in the Flexibles segment). While mechanically passed through, severe inflation at the consumer level risks future demand destruction or accelerates the shift to cheaper, private-label alternatives.
Deleveraging Timeline Remains Extended
Net debt sits at $12.89B. The company guided December 2026 leverage to 3.5x-3.6x. While stable, this means the balance sheet will remain well above management's long-term target of 2.5x-3.0x through the end of the calendar year. Until this is resolved via free cash flow generation or non-core divestiture proceeds, aggressive capital returns (like share buybacks) are off the table.
Other KPIs
Accelerating. Adjusted Free Cash Flow surged 48% YoY in the quarter, bringing the full-year figure to $1,303 million (after funding $290 million in integration/restructuring costs). This strong cash generation helps offset the elevated debt load and safely covers the $1.19B in annual dividends paid.
Accelerating. Up 57% on a constant currency basis, vastly outpacing the 35% revenue growth. The margin expanded by 180 basis points YoY to 12.3%, primarily reflecting synergy realization and aggressive cost reduction in what has historically been the lower-margin segment.
Guidance
Stable. The company is changing its fiscal year-end to December. This 'stub period' guidance reflects a steady, predictable earnings run-rate that heavily relies on continued synergy capture to offset a potentially tepid consumer environment.
Stable. This confirms that deleveraging will be a multi-year journey. While not worsening, it pushes the <3.0x target well into calendar 2027, barring sudden large divestitures.
Key Questions
Price/Mix Headwinds
Despite successfully passing through $280 million in raw material inflation, the underlying price/mix was a 1% headwind to sales. Are customers actively trading down to lower-margin packaging solutions, or is this related to specific customer concessions to secure volume?
Non-Core Divestiture Timeline
You've successfully reached agreements for several smaller divestitures, but what is the current timeline and expected valuation environment for the larger non-core assets, specifically the North American beverage business, now that volumes have begun to stabilize?
Transition Period Cash Flow Dynamics
With the shift to a December fiscal year-end, how should we model the working capital seasonality in the upcoming six-month transition period, especially given the strategic inventory builds executed earlier in the year?